FAUC-365
CAS No. 474432-66-1
FAUC-365( FAUC-365 Benzo[b]thiophene-2-carboxylic acid {4-[4-(2,3-dichloro- phenyl)-piperazin-1-yl]-butyl}-amide )
Catalog No. M27448 CAS No. 474432-66-1
FAUC-365 is a D3 dopamine receptor agonist.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 102 | Get Quote |
|
10MG | 155 | Get Quote |
|
25MG | 305 | Get Quote |
|
50MG | 484 | Get Quote |
|
100MG | 700 | Get Quote |
|
500MG | 1458 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFAUC-365
-
NoteResearch use only, not for human use.
-
Brief DescriptionFAUC-365 is a D3 dopamine receptor agonist.
-
DescriptionFAUC-365 is a D3 dopamine receptor agonist.(In Vitro):As a dichloro derivative, FAUC-365 revealed D3 affinities that were comparable to its methoxy-substituted analogs, however, the selectivities of FAUC-365 against 5HT-1A, 5-HT2, and R1 were substantially higher, which was demonstrated by the extraordinary selectivity ratios of 17600, 7200, 5200, and 680 over D1, D2long, D2short, and D4, respectively, were determined for FAUC-365 with Ki of 0.50 nM. In addition, the benzothiophene analog FAUC 346 and its oxa analog showed partial agonist character with EC50 values at 0.36 and 1.5 nM, respectively .
-
In Vitro——
-
In Vivo——
-
SynonymsFAUC-365 Benzo[b]thiophene-2-carboxylic acid {4-[4-(2,3-dichloro- phenyl)-piperazin-1-yl]-butyl}-amide
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorLOXL2|LOXL3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number474432-66-1
-
Formula Weight462.43
-
Molecular FormulaC23H25Cl2N3OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (72.07 mM)
-
SMILESClc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Octopamine hydrochlo...
Octopamine (OA), a biogenic monoamine structurally related to noradrenaline.
-
N,N-Dimethylglycine
N, N-Dimethylglycine is used as an athletic performance enhancer and immunostimulant. It is also used in the treatment of autism, epilepsy and mitochondrial disease.
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??